Mortality Rate was unsightly!!! 4/24/2013. Sepsis Quality Improvement Project

Size: px
Start display at page:

Download "Mortality Rate was unsightly!!! 4/24/2013. Sepsis Quality Improvement Project"

Transcription

1 Libby, MT Sepsis Quality Improvement Project Barb Dumont RN, Director of Quality and Risk Management Mike Julius RN, ED Manager Cathy Wolfe RN, Chief Nursing Officer. Mortality Rate was unsightly!!! percent Mortality Rate 100% 80% 60% 40% 20% 0% Discharge Status Alive 52.9% Transferred 11.8% Deceased 35.3% 1

2 Our Emergency Physician Team 2

3 Mike Julius, RN, ED Manager Dr. Raymond Zurcher, Emergency Physician Nursing Physicians Pharmacy Respiratory Laboratory Everyone 3

4 Up grade equipment that allows for invasive monitoring in ED and ICU Develop pre printed orders everyone on the same page Aggressive and early antibiotic therapy initiated Maintain SVO2 > or equal 70% Continued Quality Improvement through Emergency Medicine Committee Up graded our telemetry and monitoring (with Mindray) 4

5 Developed Approved by all committees Crossed over and implemented them in electronic documentation in Meditech Use the paper tool during down time Review Sepsis Orders Check for Antibiotics that appropriate Continue with our process improvement 5

6 First Draft Reviewed by nursing staff and physician staff. REMINDER: All orders must be dated, timed, and signed by the prescribing physician. ORDERS AND SIGNATURE 1. If Lactic acid greater than recheck Lactic Acid every hours X 2. If Lactic Acid greater than 4: central line placement and monitor ScvO 2 3. INITIAL FLUID RESUSCITATION minimum 30 ml/kg bolus recommended Pt wt: kg X 30 ml/kg = ml for initial bolus. NS 1000 ml over minutes and repeat bolus of NS 500ml until 30ml/kg met. Repeat Lactic Acid one hour after initial 30ml/kg bolus and every 4 hours X 4. Continue boluses of NS 500ml X for target CVP of greater than 8 mm Hg (greater than 12 mm Hg if mechanically ventilated) and/or MAP greater than 65 mm Hg. If unable to meet parameters contact physician for further fluid orders. 4. ANTIBIOTICS Administer the following antibiotics within 3 hours of presentation (see page two for recommendations) STAT antibiotic # 1 STAT antibiotic # 2 For meningitis: give Decadron 10 mg IV 20 minutes prior to antibiotics Goals for first six hours of resuscitation: CENTRAL LINE PLACEMENT TO ACHIEVE THE FOLLOWING CVP 8 12 mm Hg (Greater than 12 is goal if on mechanical ventilation) MAP > 65 mm Hg ScvO2 > 70% (draw sample from central line) 5. HEMODYNAMIC/TISSUE PERFUSION MONITORIN: Monitor and document CVP, MAP, and ScvO 2 every 30 minutes 6. VASOPRESSORS: Consider vasopressors if patient remains hypotensive after 30 ml/kg fluid resuscitation Norepinephrine is first choice in sever sepsis. 7. ADDITIONAL SUPPORTIVE THERAPY: If ScvO 2 remains less than 70% despite a CVP of 8 12 mm Hg non-intubated (or mm Hg if mechanically ventilated) and the addition of vasopressors consider: Transfusion Therapy: 1 unit packed red cells if Hgb less than 7 mg/dl Inotropic Therapy: DOBUTAMINE Start IV infusion at 2.5 mcg/kg/min and may titrate by 2.5 mcg/kg/min every 10 minutes to maintain ScvO 2 > 70%. Maximum dose is 40 mcg/kg/min. 8. GLUCOSE CONTROL (Goal blood glucose: mg/ml) Finger-stick blood stick every 4 hours Initiate IV insulin drip order set (non-dka) if glucose greater than 180 mg/dl 9. Other orders Date: Time: Physician Signature P a g e 1 6

7 ANTI-INFECTIVE EMPERIC THERAPY Culture should be obtained prior to administration Administer antibiotics within the first hour of recognition of severe sepsis, initiate in ER Consider combination therapy in neutropenic patients or those with Pseudomonal infections Once cultures and sensitivity have been reported begin transporting from empiric broad spectrum antibiotics to more specific antibiotic drug regimens. Reassess anti-infective regimen daily to optimize efficacy, prevent resistance, avoid toxicity, and minimize costs. Duration of therapy is 14 days (bloodstream) or 10 days (non-bloodstream): longer durations may be necessary in certain situations (i.e. endocarditis/osteomyellitis). Consider stopping anti-infective therapy if cause is found to be non-infectious. Pharmacy to renal dose adjusts medications as needed per protocol. Select anti-infective empiric regimen based on probable site of infection below: 1. Intra-abdominal Zosyn gm IV every six hours (consider renal dosing) or Tigecycline 100mg IV x 1dose then 50 mg IV every 12 hours. 2. Skin/soft tissue infection Vancomycin 1 gm IV every 12 hours. Adjust dose for goal trough levels between 10 15, or Linezolid 600 mg IV every 12 hours If necrotizing infection add Zosyn gm IV every six hours (consider renal dosing) 3. Central Line Infection: Line removal plus antibiotic therapy If MRSA suspected: Vancomycin 1 gm IV every 12 hours. Adjust dose for goal trough levels between 10 15, or Daptomycin 6 mg/kg IV every 24 hours or Linezolid 600 mg IV every 12 hours If non-mrsa (empiric therapy) Cefepime 2 gm IV every 12 hours or if PCN allergy may give Levofloxacin 750 mg IV every 24 hours (consider renal dosing) 4. Lungs (Healthcare Associated Pneumonia) Zosyn 4.5 gm IV every six hours (consider renal dosing) and Gentamycin 7 mg/kg IV every 24 hours If PCN allergy may give : Aztreonam 2 gm IV every 6 hours and Gentamycin 7 mg/kg IV every 24 hours If MRSA is suspected add to either regimen: Linezolid 600 mg IV every 12 hours or Vancomycin 1 gm IV every 12 hours, adjust dose for goal trough levels between 15 and Lungs (Community Acquired Pneumonia) Ceftriaxone 2 gm IV every 24 hours and Azithromycin 500 mg every 24 hours. If PCN allergy: may give Levofloxacin 750 mg IV every 24 hours (consider renal dosing) and Aztreonam 2 gm IV every 6 hours. If MRSA is suspected add to either regimen: Linezolid 600 mg IV every 12 hours or Vancomycin 1 gm IV every 12 hours, adjust dose for renal trough levels between Urosepsis Zosyn gm IV every 6 hours (consider renal dosing) If PCN allergy: may give Levofloxacin 750 mg IV every 24 hours (consider renal dosing) If VRE suspected give: Linezolid 600 mg IV every 12 hours. 7. Sepsis with Purpura (asplenia or hyposplenia) Ceftriaxone 2 gm IV every 24 hours or Levofloxacin 500 mg IV every 24 hours (consider renal dosing) 8. Sepsis secondary to chronic high dose steroids (Aspergillus Pneumonia) Voriconazole 6 mg/kg IV every 12 hours X 2 doses, then 3 mg/kg IV every 12 hours (consider renal dosing) or Micafungin 100 mg IV every 24 hours (preferred when CrCl < 50 ml/min 9. Persistent Fever and neutropenia after 5 days of empiric antibacterial therapy Micafungin 100 mg IV every 24 hours or Voriconazole 6 mg/kg IV every 12 hours X 2 doses, then 3 mg/kg IV every 12 hours. 10. Unknown site Vancomycin 1 gm IV every 12 hours. Adjust dose for trough levels between and Zosyn gm IV every 6 hours (consider renal dosing) and Gentamycin 7 mg/kg IV every 24 hours. P a g e 2 P a g e 1 7

8 This image cannot currently be displayed. 4/24/2013 P a g e 2 Our ED Manager manages and views the process Brings to Committee 8

9 We improved Input the data (have the numbers) 100% Mortality Rate 80% percent 60% 40% 20% 0% Discharge Status Alive % Alive % Transferred % Transferred % Deceased % Deceased % 9

Diagnosis: Allergies:

Diagnosis: Allergies: Patient Name: Diagnosis: Allergies: ICU Sepsis Version 5 1/11/17 This order set must be used with an admission order set if patient not already admitted. Nursing Orders Verify that cultures have been obtained

More information

Severe β-lactam allergy. Alternative (use for mild-moderate β-lactam allergy) therapy

Severe β-lactam allergy. Alternative (use for mild-moderate β-lactam allergy) therapy Recommended Empirical Antibiotic Regimens for MICU Patients Notes: The antibiotic regimens shown are general guidelines and should not replace clinical judgment. Always assess for antibiotic allergies.

More information

Guidebook for ED and Inpatient Sepsis Order Set Initiatives 2018

Guidebook for ED and Inpatient Sepsis Order Set Initiatives 2018 Background The leadership of the Surviving Sepsis Campaign (SSC) believes, since its inception, that both the SSC Guidelines and the SSC performance improvement indicators (1) will evolve as new evidence

More information

AnnMarie Papa, DNP,RN,CEN,NE-BC,FAEN, FAAN Clinical Director, Emergency, Medical & Observation Nursing Hospital of the University of Pennsylvania

AnnMarie Papa, DNP,RN,CEN,NE-BC,FAEN, FAAN Clinical Director, Emergency, Medical & Observation Nursing Hospital of the University of Pennsylvania AnnMarie Papa, DNP,RN,CEN,NE-BC,FAEN, FAAN Clinical Director, Emergency, Medical & Observation Nursing Hospital of the University of Pennsylvania Who Am I? Except on few occasions, the patient appears

More information

December 3, 2015 Severe Sepsis and Septic Shock Antibiotic Guide

December 3, 2015 Severe Sepsis and Septic Shock Antibiotic Guide Severe Sepsis and Septic Shock Antibiotic Guide Surviving Sepsis: The choice of empirical antimicrobial therapy depends on complex issues related to the patient s history, including drug intolerances,

More information

DRUG ALLERGIES WT: KG

DRUG ALLERGIES WT: KG DRUG AND TREATMENT Available ONLY at: BMC-B BMC-D BMC-N BMC-S Non Categorized Quality Measure Sepsis Bundle Admit to Inpatient Patient Status: Inpatient, Level of Care: Intensive Care (8), Diagnosis: Please

More information

Staging Sepsis for the Emergency Department: Physician

Staging Sepsis for the Emergency Department: Physician Staging Sepsis for the Emergency Department: Physician Sepsis Continuum 1 Sepsis Continuum SIRS = 2 or more clinical criteria, resulting in Systemic Inflammatory Response Syndrome Sepsis = SIRS + proven/suspected

More information

DRUG ALLERGIES WT: KG

DRUG ALLERGIES WT: KG DRUG AND TREATMENT Available ONLY at: BMC-A BMC-B BMC-C BMC-D BMC-N BMC-S BMC-T Non Categorized SUB (SUB)* SUB Alert Protocol(SUB)* SUB Alert Protocol Lab Tests(SUB)* Quality Measure Sepsis Bundle Nursing

More information

Septic Shock. Kathryn Sims, PGY I

Septic Shock. Kathryn Sims, PGY I Septic Shock Kathryn Sims, PGY I A 6 y.o. previously healthy boy presents to the ED with 7 days of fever accompanied by chills. Further history reveals the patient has also been experiencing dysuria for

More information

Core Measures SEPSIS UPDATES

Core Measures SEPSIS UPDATES Patricia Walker, RN-BC, BSN Evidence Based Practice Manager Quality Management Services UCLA Health System, Ronald Reagan Medical Center Core Measures SEPSIS UPDATES Severe Sepsis and Septic Shock Based

More information

Dilemmas in Septic Shock

Dilemmas in Septic Shock Dilemmas in Septic Shock William Janssen, M.D. Assistant Professor of Medicine National Jewish Health University of Colorado Denver Health Sciences Center A 62 year-old female presents to the ED with fever,

More information

Physician's Core Measure Pocket Guide AMI

Physician's Core Measure Pocket Guide AMI Physician's Core Measure Pocket Guide Core Measure Hotline: Ext. 4448 http://centegramedsource.com Indicator: AMI AMI VER. 9/2018 MUST document WHY no ASA unless there is documentation of contraindication

More information

Sepsis new definitions of sepsis and septic shock and Novelities in sepsis treatment

Sepsis new definitions of sepsis and septic shock and Novelities in sepsis treatment Sepsis new definitions of sepsis and septic shock and Novelities in sepsis treatment What is sepsis? Life-threatening organ dysfunction caused by a dysregulated host response to infection A 1991 consensus

More information

Immunomodulation and Sepsis in Oncological Patients. Imad Haddad, M.D. Medical Director, PICU Banner Children s Hospital at BDMC

Immunomodulation and Sepsis in Oncological Patients. Imad Haddad, M.D. Medical Director, PICU Banner Children s Hospital at BDMC Immunomodulation and Sepsis in Oncological Patients Imad Haddad, M.D. Medical Director, PICU Banner Children s Hospital at BDMC 1 Objectives Immune dys-regulation in oncological septic patients Implementation

More information

Sepsis Story At Intermountain Healthcare Intensive Medicine Clinical Program

Sepsis Story At Intermountain Healthcare Intensive Medicine Clinical Program Sepsis Story At Intermountain Healthcare 2004-2012 Intensive Medicine Clinical Program The International Surviving Sepsis Campaign Was Organized In 2002 During The ESICM International Meeting In Barcelona,

More information

Care Guideline DRAFT for review cycle 08/02/17 CARE OF THE ADULT PNEUMONIA PATIENT

Care Guideline DRAFT for review cycle 08/02/17 CARE OF THE ADULT PNEUMONIA PATIENT Care Guideline DRAFT for review cycle 08/02/17 CARE OF THE ADULT PNEUMONIA PATIENT Target Audience: All MHS employed providers within Primary Care, Urgent Care, and In-Hospital Care. The secondary audience

More information

Surviving Sepsis Campaign Guidelines 2012 & Update for David E. Tannehill, DO Critical Care Medicine Mercy Hospital St.

Surviving Sepsis Campaign Guidelines 2012 & Update for David E. Tannehill, DO Critical Care Medicine Mercy Hospital St. Surviving Sepsis Campaign Guidelines 2012 & Update for 2015 David E. Tannehill, DO Critical Care Medicine Mercy Hospital St. Louis Be appropriately aggressive the longer one delays aggressive metabolic

More information

Saving Lives: Focusing on Severe Sepsis and Septic Shock

Saving Lives: Focusing on Severe Sepsis and Septic Shock Saving Lives: Focusing on Severe Sepsis and Septic Shock Deborah Cameron, RN, CPHQ Paul Pratt, RN Glenn Russ, RN Providence Little Company of Mary Medical Center San Pedro January 18, 2011 Objectives 1.

More information

Patient Safety Safe Table Webcast: Sepsis (Part III and IV) December 17, 2014

Patient Safety Safe Table Webcast: Sepsis (Part III and IV) December 17, 2014 Patient Safety Safe Table Webcast: Sepsis (Part III and IV) December 17, 2014 Presenters Mark Blaney, RN Regional Nurse Educator CHI Franciscan Health Karen Lautermilch Director, Quality & Performance

More information

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 Mitchell M. Levy MD, MCCM Professor of Medicine Chief, Division of Pulmonary, Sleep, and Critical Care

More information

Objectives. Management of Septic Shock. Definitions Progression of sepsis. Epidemiology of severe sepsis. Major goals of therapy

Objectives. Management of Septic Shock. Definitions Progression of sepsis. Epidemiology of severe sepsis. Major goals of therapy Objectives Management of Septic Shock Review of the Evidence and Implementation of Pediatric Guidelines at Christus Santa Rosa Manish Desai, M.D. PL 5 2 nd year Pediatric Critical Care Fellow Review of

More information

Sepsis: Identification and Management in an Acute Care Setting

Sepsis: Identification and Management in an Acute Care Setting Sepsis: Identification and Management in an Acute Care Setting Dr. Barbara M. Mills DNP Director Rapid Response Team/ Code Resuscitation Stony Brook University Medical Center SEPSIS LECTURE NPA 2018 OBJECTIVES

More information

PHYSIOLOGY AND MANAGEMENT OF THE SEPTIC PATIENT

PHYSIOLOGY AND MANAGEMENT OF THE SEPTIC PATIENT PHYSIOLOGY AND MANAGEMENT OF THE SEPTIC PATIENT Melanie Sanchez, RN, MSNE, OCN, CCRN Clinical Nurse III City of Hope National Medical Center HOW THE EXPERTS TREAT HEMATOLOGIC MALIGNANCIES LAS VEGAS, NV

More information

CARE OF THE ADULT PNEUMONIA PATIENT

CARE OF THE ADULT PNEUMONIA PATIENT Care Guideline CARE OF THE ADULT PNEUMONIA PATIENT Target Audience: The target audience for this Care Guideline is all MultiCare providers and staff, including those associated with our clinically integrated

More information

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG DRUG AND TREATMENT Available ONLY at: BMC-B BMC-D BMC-N BMC-S Nursing Orders Communication Order If CVP unavailable, administer fluid boluses every 30 minutes except monitor O2 requirements Comments: Every

More information

John Park, MD Assistant Professor of Medicine

John Park, MD Assistant Professor of Medicine John Park, MD Assistant Professor of Medicine Faculty photo will be placed here park.john@mayo.edu 2015 MFMER 3543652-1 Sepsis Out with the Old, In with the New Mayo School of Continuous Professional Development

More information

Critical Care Treatment Guidelines

Critical Care Treatment Guidelines Critical Care Treatment Guidelines West Virginia Office of Emergency Medical Services CCT Guidelines CCT Guidelines TABLE OF CONTENTS Preface Acknowledgments Using the Guidelines INITIAL TREATMENT / UNIVERSAL

More information

Sepsis Early Recognition and Management. Therese Hughes, PhD, MPA, RN

Sepsis Early Recognition and Management. Therese Hughes, PhD, MPA, RN Sepsis Early Recognition and Management Therese Hughes, PhD, MPA, RN 1 Sepsis a Deadly Progression Affects millions around the world each year, killing one in four Contributes to approximately 50% of all

More information

Initial Resuscitation of Sepsis & Septic Shock

Initial Resuscitation of Sepsis & Septic Shock Initial Resuscitation of Sepsis & Septic Shock Dr. Fatema Ahmed MD (Critical Care Medicine) FCPS (Medicine) Associate professor Dept. of Critical Care Medicine BIRDEM General Hospital Is Sepsis a known

More information

MONTEFIORE MEDICAL CENTER

MONTEFIORE MEDICAL CENTER DEPARTMENT OF PHARMACY MONTEFIORE MEDICAL CENTER SUBJECT: MANUAL CODE: Restricted Drugs Policy, Antibiotic Restriction PH-R-5 DATE ISSUED: August, 1976 DATE REVISED: September 2000, October 2003, September

More information

Printed copies of this document may not be up to date, obtain the most recent version from

Printed copies of this document may not be up to date, obtain the most recent version from Children s Acute Transport Service Clinical Guidelines Septic Shock Document Control Information Author Claire Fraser P.Ramnarayan Author Position tanp CATS Consultant Document Owner E. Polke Document

More information

INTENSIVE CARE MEDICINE CPD EVENING. Dr Alastair Morgan Wednesday 13 th September 2017

INTENSIVE CARE MEDICINE CPD EVENING. Dr Alastair Morgan Wednesday 13 th September 2017 INTENSIVE CARE MEDICINE CPD EVENING Dr Alastair Morgan Wednesday 13 th September 2017 WHAT IS NEW IN ICU? (RELEVANT TO ANAESTHETISTS) Not much! SURVIVING SEPSIS How many deaths in England were thought

More information

EFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK. Alexandria Rydz

EFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK. Alexandria Rydz EFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK Alexandria Rydz BACKGROUND- SEPSIS Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated

More information

Physician Orders ADULT Order Set: Respiratory Failure Orders

Physician Orders ADULT Order Set: Respiratory Failure Orders [R] = will be ordered Height: cm Weight: kg Allergies: [ ] No known allergies [ ]Medication allergy(s): [ ] Latex allergy [ ]Other: Admission/Transfer/Discharge [ ] Patient Status Initial Inpatient Attending

More information

CARE PATHWAY FOR CHILDREN AND YOUNG PERSONS WITH FEBRILE NEUTROPENIA, NEUTROPENIC SEPSIS OR SUSPECTED CENTRAL VENOUS LINE INFECTIONS

CARE PATHWAY FOR CHILDREN AND YOUNG PERSONS WITH FEBRILE NEUTROPENIA, NEUTROPENIC SEPSIS OR SUSPECTED CENTRAL VENOUS LINE INFECTIONS CARE PATHWAY FOR CHILDREN AND YOUNG PERSONS WITH FEBRILE NEUTROPENIA, NEUTROPENIC SEPSIS OR SUSPECTED CENTRAL VENOUS LINE INFECTIONS This Care Pathway has been developed by a multidisciplinary team. It

More information

Session 1: Circuit, Anticoagulation and Monitoring. Ashita Tolwani, MD, MSc Noel Oabel, BSN, RN, CNN 2019

Session 1: Circuit, Anticoagulation and Monitoring. Ashita Tolwani, MD, MSc Noel Oabel, BSN, RN, CNN 2019 Session 1: Circuit, Anticoagulation and Monitoring Ashita Tolwani, MD, MSc Noel Oabel, BSN, RN, CNN 2019 Goals n Learn how to set up citrate anticoagulation for CVVH, CVVHD, CVVHDF using Prismaflex n Determine

More information

Sepsis Update Allina Critical Care Conference February 28, 2018

Sepsis Update Allina Critical Care Conference February 28, 2018 Sepsis Update Allina Critical Care Conference February 28, 2018 Sandy Fritzlar, MD Medical Director of the Allina Sepsis Program Emergency Care Consultants OBJECTIVES A brief HISTORY of Sepsis Understand

More information

Surviving Sepsis: A CRASH Course. Justin Jones, PharmD Sanford Medical Center, Fargo Staff Education 2015

Surviving Sepsis: A CRASH Course. Justin Jones, PharmD Sanford Medical Center, Fargo Staff Education 2015 Surviving Sepsis: A CRASH Course Justin Jones, PharmD Sanford Medical Center, Fargo Staff Education 2015 Disclosures No financial conflicts of interest Abbreviations ULN Upper limit of normal SVCO2 Central

More information

Sepsis. From EMS to ER to ICU. What we need to be doing

Sepsis. From EMS to ER to ICU. What we need to be doing Sepsis From EMS to ER to ICU What we need to be doing NEHAL BHATT, MD ATHENS PULMONARY, CRITICAL CARE AND SLEEP Objectives 1. Define the changes to the definition of Sepsis 2. Describe the assessment,

More information

Septic Shock. Rontgene M. Solante, MD, FPCP,FPSMID

Septic Shock. Rontgene M. Solante, MD, FPCP,FPSMID Septic Shock Rontgene M. Solante, MD, FPCP,FPSMID Learning Objectives Identify situations wherein high or low BP are hemodynamically significant Recognize complications arising from BP emergencies Manage

More information

The Septic Patient. Dr Arunraj Navaratnarajah. Renal SpR Imperial College NHS Healthcare Trust

The Septic Patient. Dr Arunraj Navaratnarajah. Renal SpR Imperial College NHS Healthcare Trust The Septic Patient Dr Arunraj Navaratnarajah Renal SpR Imperial College NHS Healthcare Trust Objectives of this session Define SIRS / sepsis / severe sepsis / septic shock Early recognition of Sepsis The

More information

Sepsis overview. Dr. Tsang Hin Hung MBBS FHKCP FRCP

Sepsis overview. Dr. Tsang Hin Hung MBBS FHKCP FRCP Sepsis overview Dr. Tsang Hin Hung MBBS FHKCP FRCP Epidemiology Sepsis, severe sepsis, septic shock Pathophysiology of sepsis Recent researches and advances From bench to bedside Sepsis bundle Severe sepsis

More information

Potential Conflicts of Interests

Potential Conflicts of Interests Potential Conflicts of Interests Research Grants Agency for Healthcare Research and Quality Akers Bioscience, Inc. Pfizer, Inc. Scientific Advisory Boards Pfizer, Inc. Cadence Pharmaceuticals Kimberly

More information

Osteomyelitis Samir S. Shah, MD, MSCE

Osteomyelitis Samir S. Shah, MD, MSCE Osteomyelitis Samir S. Shah, MD, MSCE Professor, Department of Pediatrics University of Cincinnati College of Medicine Director, Division of Hospital Medicine Attending Physician in Infectious Diseases

More information

Frank Sebat, MD - June 29, 2006

Frank Sebat, MD - June 29, 2006 Types of Shock Hypovolemic Shock Low blood volume decreasing cardiac output. AN INTEGRATED SYSTEM OF CARE FOR PATIENTS AT RISK SHOCK TEAM and RAPID RESPONSE TEAM Septic or Distributive Shock Decrease in

More information

Sepsis Management: Past, Present, and Future

Sepsis Management: Past, Present, and Future Sepsis Management: Past, Present, and Future Benjamin Ferrell, MD Tennessee ACP Meeting October 28, 2017 Learning Objectives Identify the most updated definition and clinical criteria for sepsis Describe

More information

Inpatient Quality Reporting Program

Inpatient Quality Reporting Program SEP-1 Early Management Bundle, Severe Sepsis/Septic Shock Part II Questions and Answers Moderator: Candace Jackson, RN Inpatient Quality Reporting (IQR) Program Lead Hospital Inpatient Value, Incentives,

More information

Organ Donor Management Recommended Guidelines ADULT CARDIAC DEATH (DCD)

Organ Donor Management Recommended Guidelines ADULT CARDIAC DEATH (DCD) Date: Time: = Always applicable = Check if applicable ADMISSION INSTRUCTIONS Move to Comfort Care Note in chart. Contact initiated with BC Transplant Consent for Organ Donation obtained Code Status: Full

More information

The Ever Changing World of Sepsis Management. Laura Evans MD MSc Medical Director of Critical Care Bellevue Hospital

The Ever Changing World of Sepsis Management. Laura Evans MD MSc Medical Director of Critical Care Bellevue Hospital The Ever Changing World of Sepsis Management Laura Evans MD MSc Medical Director of Critical Care Bellevue Hospital COI Disclosures No financial interests to disclose Learning Objectives Review the evolution

More information

Early Goal-Directed Therapy

Early Goal-Directed Therapy Early Goal-Directed Therapy Where do we stand? Jean-Daniel Chiche, MD PhD MICU & Dept of Host-Pathogen Interaction Hôpital Cochin & Institut Cochin, Paris-F Resuscitation targets in septic shock 1 The

More information

Evaluation of Vancomycin Continuous Infusion in Trauma Patients

Evaluation of Vancomycin Continuous Infusion in Trauma Patients OBJECTIVES Evaluation of Vancomycin Continuous Infusion in Trauma Patients Brittany D. Bissell, Pharm.D. PGY-2 Critical Care Pharmacy Resident Jackson Memorial Hospital Miami, Florida Evaluate the potential

More information

Neutropenic Fever 1 InpatientPediatric Treatment

Neutropenic Fever 1 InpatientPediatric Treatment Neutropenic Fever InpatientPediatric Treatment (Hematologic Cancers and Stem Cell Patients) te: This algorithm should not be used for patients receiving CAR cell therapy. Page of 8 Patient presents with

More information

Organ Donor Management Recommended Guidelines ADULT Brain Death (NDD)

Organ Donor Management Recommended Guidelines ADULT Brain Death (NDD) Date: Time: = Always applicable = Check if applicable ADMISSION INSTRUCTIONS Neurological Determination of Death (NDD) has been performed by at least 2 licensed physicians Contact initiated with BC Transplant

More information

Updates On Sepsis Updates based on 2016 updates on sepsis from The International Surviving Sepsis Campaign

Updates On Sepsis Updates based on 2016 updates on sepsis from The International Surviving Sepsis Campaign Updates On Sepsis Updates based on 2016 updates on sepsis from The International Surviving Sepsis Campaign Dr. Joseph K Erbe, DO Medical Director Hospitalist Division of Medicine Objectives 1. Review the

More information

Inpatient Quality Reporting Program

Inpatient Quality Reporting Program SEP-1 Early Management Bundle, Severe Sepsis/Septic Shock Part III: Measure updates and Abstraction Guidance Questions and Answers Moderator: Candace Jackson, RN Inpatient Quality Reporting (IQR) Program

More information

The syndrome formerly known as. Severe Sepsis. James Rooks MD. Coordinator of critical care education OU College of Medicine, Tulsa

The syndrome formerly known as. Severe Sepsis. James Rooks MD. Coordinator of critical care education OU College of Medicine, Tulsa The syndrome formerly known as Severe Sepsis James Rooks MD Coordinator of critical care education OU College of Medicine, Tulsa Disclosures I have no actual or practical conflicts of interest in relation

More information

Sepsis is an important issue. Clinician s decision-making capability. Guideline recommendations

Sepsis is an important issue. Clinician s decision-making capability. Guideline recommendations Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012 Clinicians decision-making capability Guideline recommendations Sepsis is an important issue 8.7%

More information

Sepsis - A Year in Transition

Sepsis - A Year in Transition Sepsis - A Year in Transition Todd L. Allen, MD, FACEP Chair, Emergency Department Development Team; Assistant Quality Officer, Institute for Healthcare Leadership Russell R. Miller, III, MD, MPH, FCCM

More information

Sepsis 3 & Early Identification. Disclosures. Objectives 9/19/2016. David Carlbom, MD Medical Director, HMC Sepsis Program

Sepsis 3 & Early Identification. Disclosures. Objectives 9/19/2016. David Carlbom, MD Medical Director, HMC Sepsis Program Sepsis 3 & Early Identification David Carlbom, MD Medical Director, HMC Sepsis Program Disclosures I have no relevant financial relationships with a commercial interest and will not discuss off-label use

More information

Controversies in Hospital Medicine: Critical Care. Vasopressors, Steroids, and Insulin Therapy

Controversies in Hospital Medicine: Critical Care. Vasopressors, Steroids, and Insulin Therapy Controversies in Hospital Medicine: Critical Care Vasopressors, Steroids, and Insulin Therapy Douglas Fish, Pharm.D. Professor of Pharmacy, University of Colorado Denver Clinical Specialist in Critical

More information

Sepsis Care and the New Core Measures. Daniel S. Hagg, MD January 15, 2016

Sepsis Care and the New Core Measures. Daniel S. Hagg, MD January 15, 2016 Sepsis Care and the New Core Measures Daniel S. Hagg, MD January 15, 2016 Outline What is sepsis? A brief history of sepsis care How should we take care of septic patients now? Core measures What strategies

More information

PEDIATRIC LIFEGIFT BRAIN DEATH PLAN

PEDIATRIC LIFEGIFT BRAIN DEATH PLAN PHYSICIAN S Diagnosis Weight Allergies Admit/Discharge/Transfer THIS PLAN IS TO BE ED ONLY ON THE LIFEGIFT ENCOUNTER, WITH DR LIFEGIFT AS THE ATTENDING. Patient Status Pt Status: Inpatient (Inpatient only

More information

9/25/2017. Nothing to disclose

9/25/2017. Nothing to disclose Nothing to disclose Jessie O Neal, PharmD, BCCCP Critical Care Clinical Pharmacist University of New Mexico Hospital New Mexico Society of Health-System Pharmacists 2017 Balloon Fiesta Symposium Explain

More information

Nothing to disclose 9/25/2017

Nothing to disclose 9/25/2017 Jessie O Neal, PharmD, BCCCP Critical Care Clinical Pharmacist University of New Mexico Hospital New Mexico Society of Health-System Pharmacists 2017 Balloon Fiesta Symposium Nothing to disclose 1 Explain

More information

Septic shock. Babak Tamizi Far M.D Isfahan university of medical sciences

Septic shock. Babak Tamizi Far M.D Isfahan university of medical sciences Septic shock Babak Tamizi Far M.D Isfahan university of medical sciences Definitions Used to Describe the Condition of Septic Patients Approximately 750,000 cases of severe sepsis or septic shock occur

More information

Sepsis Management Update 2014

Sepsis Management Update 2014 Sepsis Management Update 2014 Laura J. Moore, MD, FACS Associate Professor, Department of Surgery The University of Texas Health Science Center, Houston Medical Director, Shock Trauma ICU Texas Trauma

More information

Fluid Resuscitation and Monitoring in Sepsis. Deepa Gotur, MD, FCCP Anne Rain T. Brown, PharmD, BCPS

Fluid Resuscitation and Monitoring in Sepsis. Deepa Gotur, MD, FCCP Anne Rain T. Brown, PharmD, BCPS Fluid Resuscitation and Monitoring in Sepsis Deepa Gotur, MD, FCCP Anne Rain T. Brown, PharmD, BCPS Learning Objectives Compare and contrast fluid resuscitation strategies in septic shock Discuss available

More information

No conflicts of interest to disclose

No conflicts of interest to disclose No conflicts of interest to disclose Introduction Epidemiology Surviving sepsis guidelines 2012 Updates Resuscitation protocols Map Goals Transfusion Sepsis-3 Bundle Management Questions Sepsis is a systemic,

More information

Neutropenic Fever. CID 2011; 52 (4):e56-e93

Neutropenic Fever.  CID 2011; 52 (4):e56-e93 Neutropenic Fever www.idsociety.org CID 2011; 52 (4):e56-e93 Definitions Fever: Single oral temperature of 101 F (38.3 C) Temperature 100.4 F (38.0 C) over 1 hour Neutropenia: ANC < 500 cells/mm 3 Expected

More information

FLUID RESUSCITATION AND MONITORING IN SEPSIS PROTOCOLIZED VS USUAL CARE DEEPA BANGALORE GOTUR MD, FCCP ASSISTANT PROFESSOR, WEILL CORNELL MEDICAL

FLUID RESUSCITATION AND MONITORING IN SEPSIS PROTOCOLIZED VS USUAL CARE DEEPA BANGALORE GOTUR MD, FCCP ASSISTANT PROFESSOR, WEILL CORNELL MEDICAL FLUID RESUSCITATION AND MONITORING IN SEPSIS PROTOCOLIZED VS USUAL CARE DEEPA BANGALORE GOTUR MD, FCCP ASSISTANT PROFESSOR, WEILL CORNELL MEDICAL COLLEGE NOVEMBER 10 TH 2017 TEXAS SCCM SYMPOSIUM Disclosures

More information

Standardize comprehensive care of the patient with severe traumatic brain injury

Standardize comprehensive care of the patient with severe traumatic brain injury Trauma Center Practice Management Guideline Iowa Methodist Medical Center Des Moines Management of Patients with Severe Traumatic Brain Injury (GCS < 9) ADULT Practice Management Guideline Contact: Trauma

More information

Sepsis care and the new core measures

Sepsis care and the new core measures Sepsis care and the new core measures Daniel S. Hagg, MD January 15, 2016 Outline What is sepsis? A brief history of sepsis care How should we take care of septic patients now? Core measures What strategies

More information

Guidelines are the Future of Sepsis Management Pro

Guidelines are the Future of Sepsis Management Pro Guidelines are the Future of Sepsis Management Pro R. Phillip Dellinger MD, MCCM Professor and Chair of Medicine Director Adult Health Institute Senior Critical Care Attending Camden NJ USA Objectives

More information

Evidence-Based. Management of Severe Sepsis. What is the BP Target?

Evidence-Based. Management of Severe Sepsis. What is the BP Target? Evidence-Based Management of Severe Sepsis Michael A. Gropper, MD, PhD Professor and Vice Chair of Anesthesia Director, Critical Care Medicine Chair, Quality Improvment University of California San Francisco

More information

R2R: Severe sepsis/septic shock. Surat Tongyoo Critical care medicine Siriraj Hospital

R2R: Severe sepsis/septic shock. Surat Tongyoo Critical care medicine Siriraj Hospital R2R: Severe sepsis/septic shock Surat Tongyoo Critical care medicine Siriraj Hospital Diagnostic criteria ACCP/SCCM consensus conference 1991 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

More information

Sepsis Awareness and Education

Sepsis Awareness and Education Sepsis Awareness and Education Meets the updated New York State Department of Health (NYSDOH) requirements for Infection Control and Barrier Precautions coursework Element VII: Sepsis Awareness and Education

More information

Sepsis or Severe Sepsis? Is there a right thing, and how do we do it?

Sepsis or Severe Sepsis? Is there a right thing, and how do we do it? Sepsis or Severe Sepsis? Is there a right thing, and how do we do it? Steven Q Simpson, MD, FCCP, FACP Professor of Medicine Division of Pulmonary and Critical Care University of Kansas Disclosures No

More information

Early Goal Directed Therapy in 2015: What Did the Big Trials Teach us?

Early Goal Directed Therapy in 2015: What Did the Big Trials Teach us? Early Goal Directed Therapy in 2015: What Did the Big Trials Teach us? Mitchell M. Levy MD, FCCM Professor of Medicine Chief, Division of Pulmonary, Sleep, and Critical Care Warren Alpert Medical School

More information

Sepsis Update: Focus on Early Recognition and Intervention. Disclosures

Sepsis Update: Focus on Early Recognition and Intervention. Disclosures Sepsis Update: Focus on Early Recognition and Intervention Jessie Roske, MD October 2017 Disclosures I have no actual or potential conflict of interest in relation to this program/presentation. I will

More information

BC Sepsis Network Emergency Department Sepsis Guidelines

BC Sepsis Network Emergency Department Sepsis Guidelines The provincial Sepsis Clinical Expert Group developed the BC, taking into account the most up-to-date literature (references below) and expert opinion. For more information about the guidelines, and to

More information

Surviving Sepsis. Brian Woodcock MBChB MRCP FRCA FCCM

Surviving Sepsis. Brian Woodcock MBChB MRCP FRCA FCCM 1 Surviving Sepsis Brian Woodcock MBChB MRCP FRCA FCCM 2 Disclosures No conflicts of interest 3 Sepsis Principles of management of septic shock in the operating room "Surviving Sepsis" guidelines 4 Add-on

More information

Adult Inpatient Antibiogram. Antimicrobial Susceptibilities of Frequently Recovered Clinical Isolates. January to December 2016

Adult Inpatient Antibiogram. Antimicrobial Susceptibilities of Frequently Recovered Clinical Isolates. January to December 2016 Adult Inpatient Antibiogram Antimicrobial Susceptibilities of Frequently Recovered Clinical Isolates January to December 2016 Department of Pathology Camille Hamula, PhD Director, Clinical Microbiology

More information

Update in Sepsis. Conflicts of Interest: None. Bill Janssen, M.D.

Update in Sepsis. Conflicts of Interest: None. Bill Janssen, M.D. Update in Sepsis Bill Janssen, M.D. Associate Professor of Medicine National Jewish Health University of Colorado Denver Conflicts of Interest: None A 62 year-old female presents to the ED with fever,

More information

Surviving Sepsis Campaign

Surviving Sepsis Campaign Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis/Septic Shock An Overview By professor Ahmad Alaysh BMC-MICU 1 Surviving Sepsis A global program to Reduce mortality rates in severe

More information

** Medication exercises ** NICU Phase II

** Medication exercises ** NICU Phase II ** Medication exercises ** NICU Phase II A) Baby A has had a bowel resection six hours ago. She weighs 3 kg. Post-op, she is quite agitated and she is on a fentanyl drip at 2 micrograms/kg/hr (#1). She

More information

SEPSIS PLAN - Phase:.

SEPSIS PLAN - Phase:. - Phase:. UMC Health System PHYSICIAN S Diagnosis Weight Allergies Patient Care Vital Signs Per Unit Standards Patient Activity Bedrest Bedrest Bathroom Privileges Bedrest Up to Bedside Commode Only Up

More information

DKA Adult ICU Powerplan

DKA Adult ICU Powerplan DKA Adult ICU Powerplan Key Points for ED to ICU DKA power plan In addition to NS fluids and maintenance the regular insulin drip will either already be infusing from ED or needs to be initiated. Regular

More information

DIAGNOSIS CRITERIA RECOMMENDATIONS FOR CRITERIA

DIAGNOSIS CRITERIA RECOMMENDATIONS FOR CRITERIA DIAGNOSIS CRITERIA RECOMMENDATIONS F CRITERIA Fever Temperature > 38.3 C (101 F) If infection is suspected, evaluate SIRs Criteria for Sepsis diagnosis Sepsis (Suspected infection, 1-2 SIRs Criteria w/o

More information

Objectives. Epidemiology of Sepsis. Review Guidelines for Resuscitation. Tx: EGDT, timing/choice of abx, activated

Objectives. Epidemiology of Sepsis. Review Guidelines for Resuscitation. Tx: EGDT, timing/choice of abx, activated Update on Surviving Sepsis 2008 Objectives Epidemiology of Sepsis Definition of Sepsis and Septic Shock Review Guidelines for Resuscitation Dx: Lactate, t cultures, SVO2 Tx: EGDT, timing/choice of abx,

More information

LIFEGIFT BRAIN DEATH PLAN

LIFEGIFT BRAIN DEATH PLAN Diagnosis Weight Allergies Admit/Discharge/Transfer ***THIS PLAN IS TO BE ED ONLY ON THE LIFEGIFT ENCOUNTER, WITH DR LIFEGIFT AS THE ATTENDING*** Patient Status Pt Status: Inpatient (Inpatient only procedure)

More information

PHYSICIAN S ORDERS Page 1 of 5 PNEUMONIA. Resuscitation (Code)Status: Admit to: Diagnosis: Pneumonia Other: Consult:

PHYSICIAN S ORDERS Page 1 of 5 PNEUMONIA. Resuscitation (Code)Status: Admit to: Diagnosis: Pneumonia Other: Consult: Inpatient Observation Bed Type: Med/Surg PHYSICIAN S ORDERS Page 1 of 5 Satellite Telemetry Telemetry ICU Resuscitation (Code)Status: Admit to: Diagnosis: Pneumonia Other: Consult: Condition: Stable Guarded

More information

2016 Sepsis Update: Pearls, Pitfalls, and Core Measure Quicksand

2016 Sepsis Update: Pearls, Pitfalls, and Core Measure Quicksand 2016 Sepsis Update: Pearls, Pitfalls, and Core Measure Quicksand Jack Perkins, MD FACEP, FAAEM, FACP Assistant Professor of Emergency and Internal Medicine Virginia Tech Carilion School of Medicine Why

More information

Updates in Sepsis 2017

Updates in Sepsis 2017 Mortality Cases Total U.S. Population/1,000 Updates in 2017 Joshua Solomon, M.D. Associate Professor of Medicine National Jewish Health University of Colorado Denver Background New Definition of New Trials

More information

MAKING SENSE OF IT ALL AUGUST 17

MAKING SENSE OF IT ALL AUGUST 17 MAKING SENSE OF IT ALL AUGUST 17 @SepsisUK Dr Ron Daniels B.E.M. CEO, UK Sepsis Trust CEO, Global Sepsis Alliance Special Adviser to WHO SCALE AND BURDEN @sepsisuk Dr Ron Daniels B.E.M. CEO, UK Sepsis

More information

Daptomycin in Clinical Practice. Paolo Grossi

Daptomycin in Clinical Practice. Paolo Grossi Clinica delle Malattie Infettive e Tropicali Università degli Studi dell Insubria Ospedale di Circolo e Fondazione Macchi, Varese Second Opinion Infettivologica Centro Nazionale Trapianti, ISS, Roma Daptomycin

More information

Prospective audit and feedback of piperacillin-tazobactam use in a 1115 bed acute care hospital

Prospective audit and feedback of piperacillin-tazobactam use in a 1115 bed acute care hospital Prospective audit and feedback of piperacillin-tazobactam use in a 1115 bed acute care hospital Final Results Nathan Beahm, BSP, PharmD(student) September 10, 2016 Objectives Review background information

More information

SARASOTA MEMORIAL HOSPITAL DEPARTMENT POLICY

SARASOTA MEMORIAL HOSPITAL DEPARTMENT POLICY PS1006 SARASOTA MEMORIAL HOSPITAL DEPARTMENT POLICY TITLE: PHARMACEUTICALS FOR CRITICAL CARE AREAS, HEMODIALYSIS, PACU, EMERGENCY CARE CENTER, CARDIAC CARE AREAS, NEURO PROGRESSIVE CARE, AND THE MECKLER

More information

Neutropenic Fever 1 InpatientPediatric Treatment

Neutropenic Fever 1 InpatientPediatric Treatment Neutropenic Fever 1 InpatientPediatric Treatment (Solid Tumors) Note: This algorithm should not be used for patients receiving CAR cell therapy. Page 1 of 7 Patient presents with fever or develops fever

More information

Emergency Department Guideline. Anaphylaxis

Emergency Department Guideline. Anaphylaxis Emergency Department Guideline Inclusion criteria: 1. Acute onset of an illness (minutes to hours) with a AND (b OR c): a. Skin and/or mucosa (pruritus, flushing, hives, angioedema) b. Respiratory compromise

More information